In May 2022, Italy introduced a new national transparency law designed to regulate relationships between pharmaceutical and medical device manufacturers and individuals or organizations in the healthcare sector. The law aims to increase transparency around financial relationships between manufacturers and healthcare professionals, helping to combat corruption and promote accountability.